Eversept Partners’s Omnicell OMCL Stock Holding History

Eversept Partners’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-98,366	Closed	-$14.9M	–	118
2021 Q2	$14.9M	Buy	+98,366	New	+$13.7M	0.99%	30

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Eversept Partners's OMCL Position: Q3 2021 in Review

Eversept Partners sold out of Omnicell (OMCL) in Q3 2021, closing a stake of 98,366 shares — an estimated $14.9M sold.

Eversept Partners first reported a position in OMCL in Q2 2021 and held it in 1 quarter. The position peaked at $14.9M in Q2 2021. 386 funds tracked by Wall St. Rank hold OMCL as of Q3 2021.

Eversept Partners reported no remaining Omnicell position as of Q3 2021 after selling out during the quarter.
Eversept Partners sold 98,366 Omnicell shares in Q3 2021, an estimated $14.9M.
Eversept Partners first reported a position in Omnicell in Q2 2021 and held it in 1 quarter.
Eversept Partners's Omnicell position peaked at $14.9M in Q2 2021.
386 funds tracked by Wall St. Rank held Omnicell as of Q3 2021.

Based on Eversept Partners's 13F filing for Q3 2021, filed 15 Nov 2021.